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Summary Objective: To evaluate the prevalence of human papillomavirus (HPV)
cervical infection in women from the South American Guarani Indian tribe located in
the rain forest of Misiones, north-eastern Argentina; a region with a high incidence
of cervical carcinoma.
Methods: A cross-sectional cytological and HPV screening of sexually active Guarani
women from nine Indian settlements was conducted. Demographic data, information
about sexual behavior, and gynaecological history were recorded. Fresh cervical spec-
imens from 239 patients were collected, of which 207 were included in this study.
Cytology and microbiological detection were carried out by the Papanicolaou and
Gram stain methods, respectively. HPV detection and typing were analyzed by PCR
and RFLP.
Results: Pap smears in 96% of all patients showed an inﬂammatory pattern. A pos-
sible etiologic agent was found in 58% of cases: 52% Trichomonas vaginalis, 35% Gard-
nerella vaginalis and 13% Candida sp. Seven cases had cytological changes compatible
with Low Grade Intraepithelial Lesion (LGSIL), one with High Grade Intraepithelial Le-
sion (HGSIL) and one in situ cervical cancer. The prevalence for generic HPV infection
was 64% (133/207). Genotyping gave a 26% prevalence for HPV types 16/18, 13% for
types 6/11 and 30% for other types, with nine mixed infections.
Conclusion: This work reports for the ﬁrst time the prevalence of cervical HPV
infection in Guarani women. Nearly all Guarani women had some grade of cervical
disease. Generic HPV infection prevalence was elevated (64%), with predominance
*Corresponding author. Tel.: +54-3752-427687; fax: +54-3752-425414.
E-mail address: tonon@arnet.com.ar (S.A. Tonon).
1201-9712/$30.00 © 2003 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.ijid.2003.03.001
14 S.A. Tonon et al.
of high risk types 16/18. A large variety of viral types was detected, including high
to intermediate risk types not found previously in the region.
© 2003 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
Introduction
International studies have shown that cervical can-
cer is the second most common cancer in women
worldwide, with a variable prevalence according
to the implementation of successful public health
screening and treatment programmes.1
This prevalence varies from less than 5 cases
in 100,000 women in developed nations to more
than 40 in 100,000 in underdeveloped countries.
Numerous clinical, epidemiological, and molecu-
lar investigations have been performed on Human
Papillomavirus (HPV) infection in cervical cancers
and associated lesions of the low female genital
tract. Particular types of HPV, designated as high
risk types, have been detected in more than 95%
of invasive cervical neoplasias with variable per-
centages in different lesions. This fact supports
the concept that cervical infection by high risk HPV
types is necessary but not sufﬁcient for progression
to cervical neoplasia.2—6
Over the years, studies examining risk factors in
HPV infection have not been entirely consistent.7,8
Factors contributing to this have been suggested
to include differences in study populations and
also the different detection methods used. It is,
therefore, important to concentrate on particu-
lar characteristics of the study population such
as geographic location, demographic growth rate,
cultural particularities and regional human dis-
placement in the area under analysis, as well as
overall HPV prevalence, presence of speciﬁc HPV
types and sexual habits.9
In Argentina there are still no general epidemi-
ological data to indicate the overall prevalence
of HPV infection and its association with cervical
neoplasia. Nevertheless, different regional studies
have shown that cervical cancer incidence varies
widely, with values ranging from 10 cases in 100,000
women living in urban areas to nearly 40 in 100,000
in peripheral regions.10—12
The Province of Misiones is located at the
north-eastern tip of Argentina, sharing interna-
tional borders with Paraguay and Brazil. It possess
the last remnant of rainforest in the region. Mi-
siones is considered a region with both a high
incidence of cervical carcinoma and HPV genital
infection in the urban population.13
This area is experiencing an intense population
migration along the entire territory due to ecologi-
cal and economical factors. This new situation has
changed several cultural habits dramatically. Large
numbers of families leave the countryside andmove
to the suburbs of the major cities where there is in-
sufﬁcient healthcare. Furthermore, economic vari-
ations between countries, such as exchange rate
ﬂuctuations, cause international migration. These
regional differences affect public health in several
ways, sexually transmitted diseases being one of
them.
The Guarani Indian population inhabits the rain-
forest of Misiones with a population of around 1700
concentrated in more than 40 small communities.
Guarani women begin sexual activity early, after
menarche; they have multiple sexual partners and
are multiparous. Some of their partners have al-
ready had intercourse with white women of neigh-
boring towns. Until the last decade, the Indian so-
cial units had been self-sustaining, avoiding direct
exchanges with the white population of urban ar-
eas. However, the recent aforementioned econom-
ical and ecological factors have generated an im-
portant change in the Indian—white relationship,
compelling male Indians to integrate with the rural
working force in running white agricultural estab-
lishments. This abrupt social change has had a di-
rect impact on the Indian community health status,
bringing a signiﬁcant increase in sexually transmit-
ted and respiratory diseases.
This situation led us to conduct the ﬁrst reported
cervical HPV infection screening study among sex-
ually active Guarani women resident in this region,
as representative of a particular community begin-
ning to interact with the urban population.
Patients and methods
Study population
A community-based, horizontal, cervical HPV infec-
tion screening was conducted among 239 sexually
active Guarani women, aged 12—64 (median age
15), from nine Indian settlements located deep in
the rainforest in the region of Misiones, Argentina.
The group represented 93% of the local Indian fe-
male population.
All women underwent a general gynecological
examination, and a questionnaire was completed
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on their sexual and reproductive habits, including
any history of sexually transmitted diseases. During
these visits, material for cytological and virological
analysis was taken. To minimize the bias in sam-
ple collection and to ensure a sufﬁcient amount
of exfoliated cells, sampling was performed in
non-pregnant women and only if the last menstru-
ation had occurred at least one week before. All
participants gave their informed consent for in-
clusion in this study, either personally or through
their guardian, assisted by trained health and so-
cial workers. All procedures were approved by the
University of Misiones Bioethical Committee and in
accordance with the Helsinki Declaration.
Samples
Endo- and ectocervical cells were collected with
wooden spatulas for PAP smears and Gram stain, and
with cytobrush for HPV—DNA analysis. The latter
were immediately dipped in sterile PBS, pH 7.4 at
5 ◦C and transported to the laboratory on ice within
48 hours for virology processing.
Processing
Cytological diagnosis
A direct Gram stain and standard PAP processing
with the Bethesda classiﬁcation system were used
for cytological diagnosis.14
All the smears were screened and reviewed inde-
pendently by two of the authors (WN and JG) who
had no prior information on patient HPV status. The
ﬁnal diagnosis was based on the worst morphologic
picture.
HPV—DNA analysis
The polymerase chain reaction (PCR) was used for
detecting HPV—DNA in cervical scrapes. Collected
cervical cells were lysed with proteinase K and SDS
in a ﬁnal reaction volume of 500l of crude cellular
suspension. Nucleic acid was extracted by ethanol
precipitation. As a control of sample sufﬁciency,
the primer set PCO4 and GH20 was employed
to amplify a 268 bp DNA fragment of the human
beta-globin gene.15 For each assay, 100 ng of total
DNA were used as a template for HPV—DNA detec-
tion by PCR. The ampliﬁcation was performed with
the GP5+ and GP6+ consensus primers, targeting
a region of approximately 140 bp in the highly con-
served L1 ORF of the viral genome.16 CaSki and
HeLa cell DNAs were used as positive controls;
negative control included no template DNA and
was incorporated after the tenth specimen in each
test. The ampliﬁcation products were analyzed on
1.5% agarose gels, visualized with ethidium bro-
Figure 1 Representative RFLP pattern. Submarine 3%
agarose gel electrophoresis of restriction fragment
length polymorphism from a representative HPV L1 am-
plimer obtained with the MY09/11 primer set; Lanes 1
and 10: Molecular weight standard ladder (100 bp); Lane
2: Bam HI, Lane 3: Hae III, Lane 4: Hinf I, Lane 5: Dde
I, Lane 6: Pst I, Lane 7 Rsa III, Lane 8: Sau III digested
products, respectively; Lane 9: Undigested MY09/11 am-
plimer; RFLP Pattern compatible with HPV type 58.
mide staining under UV light exposure and ﬁnally
photographed.
Typing of HPV—DNA positive samples was per-
formed by restriction digestion of PCR products
(RFLP analysis) according to Bernard et al.17 Brieﬂy,
aliquots of the PCR products obtained using the de-
generate consensus primers MY09-MY11, targeting
a region of approximately 450 bp in length in the L1
ORF of the viral genome, were mixed with 10l of
seven different restriction enzymes (Bam HI, Hae
III, Dde I, Pst I, Hinf I, Sau III, and Rsa I) in separate
reactions. Digestion products were separated by
electrophoresis in 3% agarose gel and the pattern
obtained compared with published data (Figure 1).
Clinical treatments
After cytological diagnosis, all women showing signs
of vaginitis were treated at home with metronida-
zole as a single oral dose of 2 g a day for seven days
and a local application of clotrimazole for three
days, provided by agents of the Public Health Min-
istry. Patients with low grade intraepithelial lesions
(LGSIL) were scheduled for a colposcopic follow-up
at six-month intervals. Patients with high grade in-
traepithelial lesions (HGSIL) and in situ carcinoma
were surgically treated by cold knife cone excision
at the Central Provincial Hospital and proper spec-
imens were sent for histopathological evaluation.
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Table 1 Study population: age and pregnancy
distributions.
Age range Percentage
12—14 9
15—19 21
20—24 20
25—29 11
30—34 9
35—39 7
40—44 6
45—49 5
50—54 4
55—59 5
60—64 3
Pregnancies Percentage
0 15
1 16
2 23
3 22
4 15
>4 9
Results
A total of 239 women were originally involved in
this study. Interviews were successfully completed
for 228 women during the accrual period. The cer-
vical specimens from 12 women could not be eval-
uated because of problems in transport or material
quality. An additional set of nine specimens failed
to be ampliﬁed for beta-globin. This analysis there-
fore refers to the remaining 207 women.
The population under analysis had a median age
of 15, 61% being younger than 30. This particular
age distribution is common among Guarani Indians
mainly due to high mortality rates for those above
30—35 years being caused by respiratory tract in-
fections. The mean age at ﬁrst intercourse was 13
years old, ﬁrst pregnancy at 15. Polygamy reached
80%. The illiteracy rate reached 87% as is usual in
their semi-closed society. Participation in this study
represented the ﬁrst medical visit for 93% of the
women. There was no statistical correlation be-
tween any of these particular population character-
istics and HPV infection or cervical disease. Age and
pregnancy distributions are presented in Table 1.
Cytological diagnosis
Pap smears in 96% (199/207) of all patients showed
an inﬂammatory pattern. Main infections were due
to Trichomonas vaginalis in 30% (62/207), Gard-
nerella vaginalis in 20% (42/207) and Candida sp. in
8% (16/207) of patients.
Table 2 Distribution of HPV types in the Guarani
Indian population as determined by PCR-RFLP.a
High risk typesc n Percentageb
HPV 16 41 30.8
HPV 18 13 9.8
HPV 58 7 5.3
HPV 31 6 4.5
HPV 45 5 3.8
HPV 35 3 2.3
HPV 68 2 1.5
HPV 39 1 0.8
HPV 59 1 0.8
Total 79 59.4
Low risk typesc n Percentageb
HPV 6 16 12.0
HPV 11 10 7.5
HPV 53 6 4.5
HPV 56 4 3.0
CP8304 4 3.0
MM8 3 2.3
HPV 61 2 1.5
HPV 69 2 1.5
HPV 55 1 0.8
HPV 66 1 0.8
HPV 72 1 0.8
HPV 73 2 1.5
CP8061 1 0.8
ISO39 1 0.8
Total 54 39.8
Undetermined 10 7.5
a Including mixed infections.
b Over the infected population.
c According to30,32.
Seven cases (3%) hadmorphological changes com-
patible with LGSIL, one with HGSIL and, in a 47 year
old Indian, in situ cervical cancer.
HPV—DNA analysis
HPV—DNA was found in 133 of the total suitable
samples analyzed, giving a HPV infection preva-
lence of 64% in this population.
Viral genotyping gave a 26% (54/207) prevalence
for types 16/18, 13% (26/207) for types 6/11 and
30% for other types (62/207), with 4% (9/207) mixed
infections. The viral distribution is presented in
Table 2.
Discussion
Few studies can be found regarding epidemiolog-
ical surveys of cervical dysplasia and HPV cervi-
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cal infection in American Indian populations,18—21
particularly in South American tribes.22—24
This situation may be attributed to, amongst
other things, difﬁculties in accessing settlements,
cultural barriers and funding. Nevertheless, the mi-
gration, social exchange and speciﬁc sexual habits
of these communities can have an important im-
pact on public health, particularly with regard to
the interaction with inhabitants of nearby regions.
These results from generic and type-speciﬁc HPV
cervical infection analysis performed for the ﬁrst
time on 207 Guarani Indian women, are presented
as part of an ongoing study into an epidemiological
HPV survey of the region. Approximately 93% of the
sexually active and accessible female Indian pop-
ulation of this area have been studied. The study
group was representative of the Guarani population
inhabiting the rainforest of Misiones, Argentina,
characterized by early sexual initiation, early preg-
nancy, multiparity, polygamy, and illiteracy.
Although cytology showed 96% (199/207) of in-
ﬂammatory changes were mainly due to bacterial
and/or parasitic infections, in view of their hygienic
habits and almost no access to healthcare this situ-
ation can be considered as ‘normal’ for this partic-
ular population. Participation in this study enabled
direct pharmacological treatment of these infec-
tions, establishing one of the ﬁrst contacts between
this population with so called ‘white medicine’.
Cervical lesions were present in 4% of women,
LGSIL in 7 patients, HGSIL in one patient, and one
in situ carcinoma. All were treated at the central
hospital and lead to a full recovery. Taking into ac-
count that the studied population comprised 93% of
Guarani women of the region, this represents a very
high prevalence of lesions.
Cervical carcinoma is the leading cause of death
by cancer in women in the province of Misiones,
with an elevated incidence of approximately
35 cases per 100,000. This value is particularly
high compared to other regions in the country
where data are available (10 cases per 100,000 on
average).13 The Public Health Ministry therefore
considers cervical carcinoma as an endemic pathol-
ogy for this region which impacts highly on public
health.
The Guarani population showed an elevated HPV
cervical infection prevalence of 64% (133/207), only
comparable to that reported by Ter Meulen et al.
for women in Tanzania (59%, age range 15—70 years,
mean age 31).25
Demographic factors, including speciﬁc location,
sexual behavior patterns, polygamy and no effec-
tive healthcare could play a key role in sustaining
HPV reservoirs. In view of this, several health or-
ganizations have carried out multinational studies
in order to characterize the epidemiology of HPV
in Latin American, Asian and African countries with
the aim of identifying prevention strategies.2,26,27
Stressing this concept, we recall the results ob-
tained in 1998 from a case-control study carried
out by our group in white females representative
of regional urban population.11,13 HPV infection
status and associated risk factors for cervical le-
sions were analyzed, detecting an elevated number
of HPV-infected white women (43%, 85/199) with
no cytological or colposcopic sign of viral infec-
tion. A comparative high generic HPV prevalence
value in cytologically normal women (43.4%) had
only been found previously in Greenland by Kjaer
et al.8 Similar studies carried out in high incidence
areas for cervical cancer in South America, such as
in Recife, Brazil28 and Colombia29 have reported
lower HPV infection prevalences (13% and 9%,
respectively).
In this work, a population residing in the region
of Misiones showed a remarkably high prevalence
of HPV cervical infection. A possible explanation
may be the young age of the Guarani women under
analysis, a particularity of the demographics of this
tribe where 61% subjects were younger than 30
years old (median age 15). This ﬁnding is in accor-
dance with the general view that younger rather
than older women are more likely to contract
genital HPV infection, and that most of them are
transient.9 Nevertheless, it is not clear whether
the presence of HPV—DNA in women with no cervi-
cal lesions indicates a recent infection or predicts
future abnormalities.
When viral genotyping was carried out, types
16/18 (considered carcinogenic to humans (Group
1) by the International Agency for Research on
Cancer9) were found in 26% and types 6/11 (low-risk
types) in 13% of patients respectively. These preva-
lences are comparable with that of the white ur-
ban population inhabiting the region (24% and 11%
respectively).13
The presence of a large variety of viral types in
the Guarani Indian women was noteworthy (24 dif-
ferent viral types). This is in contrast to the six types
found in the white urban population.13 The distri-
bution includes types found almost exclusively in
this region (39, 59, ISO39),2 and some still undeter-
mined, that are in process of typing (Table 2).
Furthermore, when analyzing the phylogenetic
relationship30 of all HPVs affecting the Guarani
population, a strong representation of certain
groups is clearly noticed, bringing homogeneity to
the apparent diverse presence of more than 20 viral
types (Table 3). High risk and related types (A7 and
A9 groups) count for 56% (79/142) of typiﬁed posi-
tive samples, while most of the uncommon types,
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Table 3 Phylogenetic relationships of mucosal HPV
detected in Guarani women.
Phylogenetic
groupa
Viral
type
Infected
samples
Total Percentageb
A9 (high risk) 16 41
58 7 57 40%
31 6
35 3
A10 (low risk) 6 16
11 10 27 19%
55 1
A7 (high risk) 18 13
45 5
68 2 22 15%
39 1
59 1
A6 (low risk) 53 6
56 4 11 8%
66 1
A3 (low risk) CP8304 4
MM8 3
10 7%61 2
72 1
A5 (low risk) 69 2 3 2%
ISO39 1
a The phylogenetic tree of the HPV family includes
108 sequences computed for the L1 consensus primer
region using the neighbor joining method;30 The A
supergroup comprises mucosal/genital isolates, the
high risk types members being to the A7 and A9 groups.
b Relative to 130 virus genotypiﬁed in this study, HPV
73 and CP8061 have not been assigned to any deﬁni-
tive A group yet.
representing the 17% of total typiﬁed viruses, were
clustered into three groups (A6, A3 and A5).
Knowing that genomes of papillomaviruses evolve
at very slow rates, it is believed that HPV types have
existed in nearly identical molecular form since the
beginning of the humankind.31 Determining the dis-
tribution of the viral type in particular communities
is of special epidemiological interest as it consti-
tutes a potential infective reservoir susceptible to
viral spreading once external contact begin to be
established.
Having a signiﬁcant number of Guarani women in-
fected with various types of HPV, many of themwith
known carcinogenic potential not usually found in
the urban population, is an important risk factor to
be considered when implementing regional public
health policy programmes.
Another particular characteristic of the study
population is its seasonal migration between set-
tlements located in north-eastern Argentina and
southern Paraguay. This behavior is a consequence
of the nomadic behavior of the Guarani tribe and its
agricultural practices. During this transit, contact
with the white population is established, exposing
people to different sanitary conditions and hygienic
standards, making the transmission of infectious
diseases more likely.
In summary, the detection of an elevated HPV
cervical infection prevalence in Guarani women and
the presence of HPV viral types not found previously
in the urban population constitutes a potential in-
fective reservoir that can spread once contact be-
comes more frequent due to the economic and eco-
logical changes affecting the region.
This study has contributed to the implementation
of a PAP screening program and the promotion of
sexual health education within the Guarani Indian
community. These actions may help in decreasing
cervical disease and cancer cases in this population.
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